Core Insights - Air Canada and Pegasus Airlines have formed a new partnership to enhance travel options to Türkiye, specifically to Istanbul and Izmir [1][3][5] Group 1: Partnership Details - The interline agreement allows Air Canada customers to book travel on nine routes operated by Pegasus Airlines, facilitating connections through major European gateways [5][7] - The partnership aims to deepen collaboration with future codeshare and loyalty agreements, enhancing customer benefits [3][6][7] Group 2: Strategic Importance - This partnership strengthens Air Canada's connectivity to a growing market, providing customers with increased choice and flexibility in travel [5][6] - The collaboration is expected to enhance travel convenience with features like single itineraries and through-checked baggage [7] Group 3: Company Profiles - Air Canada is the largest airline in Canada, serving over 180 airports globally and is a founding member of Star Alliance [8] - Pegasus Airlines, established in 1990, operates as a low-cost carrier with a network of 158 destinations across 55 countries, focusing on budget-friendly travel [9]

Group 1 - MISTRAS Group, Inc. has scheduled a conference call for March 5, 2026, at 9:00 am Eastern Time to present its fourth quarter results for 2025 [1] - A press release with the fourth quarter results will be issued after the market closes on March 4, 2026 [1] - Individuals can pre-register for the live question and answer session at a specified link [2] Group 2 - MISTRAS Group, Inc. is a global leader in technology-enabled industrial asset integrity and laboratory testing solutions, serving critical industries such as oil & gas, aerospace & defense, power & utilities, manufacturing, and civil infrastructure [3] - The company offers a diversified portfolio of products and services, including advanced non-destructive testing, pipeline inspections, real-time condition monitoring, maintenance planning, and specialized engineering [3] - MISTRAS Group utilizes a proprietary management software suite that centralizes integrity data for predictive analytics and benchmark analysis, helping clients reduce risk, extend asset life, and optimize operational performance [3]

Company Overview - Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, particularly asthma and COPD [3] - The company is headquartered in San Diego, California and is advancing rademikibart, a next-generation antibody targeting IL-4Rα [3] Product Development - Connect Biopharma is conducting global clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD, which are areas with significant unmet medical needs [3] - The company has granted an exclusive license to Simcere Pharmaceutical Co., Ltd. for rademikibart in Greater China, with potential milestone payments up to approximately $110 million upon achieving certain development, regulatory, and commercial milestones [3] - Connect is also eligible to receive tiered royalties on net sales in Greater China, with rates up to low double-digit percentages [3] Upcoming Events - Company management will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026, at 2:40 p.m. ET [1] - A live webcast of the presentation will be available on the company's investor website, with an archived replay accessible for approximately 90 days following the conference [2]

Propelled by its leadership in Social Intelligence and Agentic AI, Sprout Social ranks as a top company across 6 categories based on customer reviewsCHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Sprout Social (Nasdaq: SPT), an industry-leading provider of social media management and analytics software, has been recognized by G2’s 2026 Best Software Awards. This milestone marks the tenth consecutive year Sprout has received this honor, which ranks the world’s most impactful software companies and products based ...

Core Insights - Cloudastructure has launched its first solar-powered security enclosure, marking its entry into off-grid autonomous security solutions for critical infrastructure [1][4] - The new solution aims to protect high-value industrial and energy assets, including solar installations and utility infrastructure, while supporting recurring SaaS revenue growth [3][4] Product Features - The solar-powered enclosure includes a 12-foot solar mast, dual high-output solar panels, integrated battery storage, dome cameras, and real-time audio deterrence, all powered by Cloudastructure's cloud-based surveillance platform [2] - Designed for remote and infrastructure-limited environments, the system offers continuous real-time monitoring, automated threat detection, and live remote guarding without the need for grid power [2] Market Positioning - The initial deployments target large-scale commercial solar fields and industrial rooftop installations for Fortune 500 companies, enhancing security in remote areas [4] - The solar-powered enclosure positions Cloudastructure to capture a growing share of the critical infrastructure protection market, driven by increasing demand for autonomous security solutions [3][5] Strategic Growth - The platform is scalable across various market applications, including renewable energy, industrial assets, and temporary security environments, expanding the total addressable market [7] - Cloudastructure's solution supports sustainability and ESG objectives by safeguarding multi-million-dollar renewable energy investments [4][7] Competitive Advantage - The company's patented security platform features cloud video surveillance with AI/ML analytics, offering a lower total cost of ownership by up to 75% compared to other systems [8] - The business model includes contract-free, month-to-month pricing and unlimited 24/7 support, enhancing its value proposition [8]

EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) is pleased to announce the appointment of Kevin MacIntosh as Chief Financial Officer of the company, effective March 16, 2026. Mr. MacIntosh has over 30 years of experience as a finance leader working in large, complex organizations within the global energy industry and brings expertise across multi-jurisdictional operations, cross-border transactions, energy trading and diverse regulatory landscapes. He has a proven t ...

LONDON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Arqit (Nasdaq: ARQQ, ARQQW), a global leader in PQC migration tooling and quantum-safe encryption, and 6WIND, a leading Green Tech company and the worldwide leader in High performance Cloud networking solutions, today announced a strategic collaboration to deliver highly scalable quantum-safe, encrypted virtual private networking (VPN) business services. These services support a wide range of enterprise, telco, and B2B use cases, including site-to-site connectivity, ...

Core Viewpoint - 20/20 BioLabs, Inc. has launched its Class A ordinary shares on the Nasdaq Capital Market under the ticker symbol "AIDX," aiming to scale growth through AI-powered blood tests for cancer and chronic disease detection [1][6]. Financing and Growth Strategy - The company has entered a contingent financing agreement that could provide up to $40 million, with the first $5 million expected to close today [2]. - The CEO emphasized that the Nasdaq listing is a significant milestone that positions the company for substantial growth through both organic means and mergers and acquisitions [6][7]. Product Offerings - 20/20 BioLabs offers OneTest™ for Cancer, an AI-powered multi-cancer early detection blood test that analyzes tumor-associated protein biomarkers, allowing for earlier detection of multiple cancers at a lower price point than competing tests [4][11]. - The upcoming OneTest for Longevity™, expected to launch by the end of February, will track inflammatory biomarkers associated with chronic diseases, enabling consumers to make lifestyle changes to reduce disease risk [5][11]. Technological Innovation - The company's diagnostics leverage AI models built with real-world data, enhancing accuracy and clinical usefulness, and allowing for convenient home access through new blood collection devices [3][11]. - The OneTest for Cancer may be the first multi-cancer early detection test that can be self-collected at home, which is a significant advancement in the field [4]. Regulatory Environment - Recent legislation passed by Congress aims to facilitate Medicare reimbursement for multi-cancer early detection tests by 2028, which could positively impact the company's market potential [4]. Investor Relations - 20/20 BioLabs has launched an Investor Relations section on its website, providing various resources for investors, including press releases, current share prices, and SEC filings [8].

TORONTO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annualized) and $0.06042 for each Preferred share ($0.725 annually). Distributions are payable March 10, 2026 to shareholders on record as at February 27, 2026. Since inception Class A shareholders have received a total of $28.32 per share and Preferred shareholders have received a total of $13.08 per share inclusive of this distribution, fo ...

Core Insights - The Q1 2026 Mid-Market Pulse Report by CBIZ reveals how middle-market business leaders are navigating challenges and planning for growth in a complex economic environment [1][2] Group 1: Strategic Priorities - 84% of middle-market businesses are prioritizing cost optimization and productivity [7] - 43% are investing in talent acquisition and retention [7] - Leaders are focused on performance, margin protection, and innovation [4] Group 2: Areas of Concern - 41% of businesses report concerns about technology and AI modernization [7] - 41% are challenged by rising labor costs [7] - Pricing pressures, working capital constraints, and shifting customer demand are also significant influences on 2026 planning [7] Group 3: Company Initiatives - CBIZ has launched "Insights. Applied." to help organizations turn strategy into action based on feedback from middle-market leaders [4] - The report reflects insights from over 1,300 CBIZ clients and client service professionals [2][5]